{"SPADE_N_14483": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14483", "Peptide Name": "Temporin-SHa G10K analog (Synthetic AMPs, XXA, UCLL1c)", "Source": "amino acid substitution, amphibians, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "FLSGIVGMLKKLF", "Sequence Length": 13, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1452.84, "PI": 10.0, "Hydrophobicity": 1.4, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Khan AI, Nazir S, Haque MNU, Maharjan R, Khan FA, Olleik H, Courvoisier-Dezord E, Maresca M, Shaheen F. 2024", "Reference": "Antibiotics (Basel). 2024 Aug 11;13(8):758. doi: 10.3390/antibiotics13080758.PubMed", "Title": "Synthesis of Second-Generation Analogs of Temporin-SHa Peptide Having Broad-Spectrum Antibacterial and Anticancer Effects"}], "Frequent Amino Acids": "LFG", "Absent Amino Acids": "ACDEHNOPQRTUWY", "Basic Residues": 2, "Acidic Residues": 0, "Hydrophobic Residues": 8, "Polar Residues": 4, "Positive Residues": 2, "Negative Residues": 0, "Net Charge": 2, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (92.31%) totemporin-SHaL: 23%, F=G=K: 15%.Chemical modification:  C-terminal amidation.Activity: active against Gram- bacteria A. baumannii DSM 30007 (MIC 3.12 uM), E. cloacae DSM 30054 (MIC 12.5 uM), E. coli ATCC 8739 (MIC 25 uM), H. pylori ATCC 43504 (MIC 3.12 uM), K. pneumonia DSM 26371 (MIC25 uM), P. aeruginosa ATCC 9027 (MIC 25 uM), Gram+ bacteria B. subtilis ATCC 6633 (MIC 3.12 uM), E. faecalis DSM 2570 (MIC 6.25 uM), E. faecium DSM 20477 (MIC 6.25 uM), and S. aureus ATCC 6538 (MIC 3.12 uM).Anticancer: Breast Cancer MCF-7, Liver Cancer HepG-2, Ovarian Cancer A2780, Pancreatic Cancer MiaPaCa-2, Prostate Cancer PC-3, Skin Cancer MNT-1, Lung Cancer A549 (IC50 11.7-64 uM).Structure:  helical in SDS.In vitro toxicity:  normal lung fibroblast IMR-90 (IC50 >100 uM) and normal Lung epithelium BEAS-2B (IC50 74.8 uM). Poor cell selectivity relative to cancer cells.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_26577", "Similarity": 1.0, "Sequence": "FLSGIVGMLKKLF"}, {"SPADE_ID": "SPADE_N_06421", "Similarity": 1.0, "Sequence": "KKLFKKILKYLKK"}, {"SPADE_ID": "SPADE_N_06422", "Similarity": 1.0, "Sequence": "KKLFKKILKYLKKL"}]}}}